{
    "clinical_study": {
        "@rank": "163091", 
        "acronym": "ATHETOID_CD", 
        "arm_group": [
            {
                "arm_group_label": "Treatment-Placebo Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Treatment on 0 day Placebo at 5th week"
            }, 
            {
                "arm_group_label": "Placebo-Treatment Group", 
                "arm_group_type": "Active Comparator", 
                "description": "Placebo on 0 day Treatment at 5th week"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aimed to compare the efficacy and safety of Meditoxin\u00ae injection for cervical\n      dystonia in adults with cerebral palsy. It is a placebo controlled, Cross-over, Double\n      blind, Randomized, Clinical trial."
        }, 
        "brief_title": "Efficacy and Safety of Meditoxin\u00ae Injection for Cervical Dystonia in Adults With Cerebral Palsy", 
        "condition": "Adult Cerebral Palsy", 
        "condition_browse": {
            "mesh_term": [
                "Cerebral Palsy", 
                "Dystonia", 
                "Paralysis", 
                "Torticollis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult cerebral palsy patients over 20 years old\n\n          -  Clinically diagnosed for cervical dystonia more than a year ago\n\n          -  No improvement with antispasmodics for the last month\n\n          -  Actively participated and gave informed consent\n\n        Exclusion Criteria:\n\n          -  Allergic to the botulinum toxin\n\n          -  Limited range of motion in cervical spine\n\n          -  Patients with fever, infection, cancer, uncontrollable seizure\n\n          -  Generalized neuromuscular junction disease patients\n\n          -  Pregnant or breast feeding women, or anticipating pregnancy until 12 weeks after the\n             study stopped\n\n          -  Patients enrolled in other studies\n\n          -  History of dose change in 4 weeks: antispasmodics, benzodiazepine, anticholinergics\n\n          -  Botulinum toxin injection history in 6 months\n\n          -  Previous history of intrathecal baclofen, selective peripheral denervation, deep\n             brain stimulation\n\n          -  Otherwise clinically non-eligible patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860196", 
            "org_study_id": "MT_IT_009"
        }, 
        "intervention": [
            {
                "arm_group_label": "Treatment-Placebo Group", 
                "intervention_name": "Meditoxin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo-Treatment Group", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 5, 2013", 
        "number_of_arms": "2", 
        "official_title": "A Placebo Controlled, Cross-over, Double Blind, Randomized, Clinical Trial to Compare the Efficacy and Safety of Meditoxin\u00ae Injection for Cervical Dystonia in Adults With Cerebral Palsy", 
        "other_outcome": [
            {
                "description": "vital sign, adverse effect", 
                "measure": "Adverse effect", 
                "safety_issue": "Yes", 
                "time_frame": "Every 4 weeks, up to 32 weeks"
            }, 
            {
                "description": "Change of cervical spine computed tomography (CT) from baseline CT at 0 week.", 
                "measure": "computed tomography (CT)", 
                "safety_issue": "Yes", 
                "time_frame": "0, 32 weeks"
            }, 
            {
                "description": "Change of videofluoroscopic swallowing study (VFSS) from baseline VFSS at 0 week.", 
                "measure": "videofluoroscopic swallowing study (VFSS)", 
                "safety_issue": "Yes", 
                "time_frame": "0, 12, 28 weeks"
            }, 
            {
                "description": "Hemoglobin, Hematocrit, RBC, WBC, WBC different cell count, Platelet\nAlkaline phosphatase, BUN, Creatinine, SGPT(ALT), SGOT(AST), Albumin, Total protein, Total bilirubin, Uric acid, Glucose, Cholesterol, LDH, Na, Ca, K, Cl\nUrine pH, Protein, Glucose, Bilirubin, Blood, WBC", 
                "measure": "Blood/Urine laboratory tests", 
                "safety_issue": "Yes", 
                "time_frame": "0, 16, 32 weeks"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change of Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) from baseline TWSTRS at 0 week.", 
            "measure": "Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)", 
            "safety_issue": "No", 
            "time_frame": "0, 16, 32 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860196"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Keewon Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Pain in numerical rating scale (NRS)", 
                "measure": "Pain in numerical rating scale (NRS)", 
                "safety_issue": "No", 
                "time_frame": "Every 4 weeks, up to 32 weeks"
            }, 
            {
                "description": "Change of Japanese Orthopaedic Association (JOA) score  from baseline Japanese Orthopaedic Association (JOA) score  at 0 week.", 
                "measure": "Japanese Orthopaedic Association (JOA) score", 
                "safety_issue": "No", 
                "time_frame": "Every 4 weeks, up to 32 weeks"
            }, 
            {
                "description": "Goal attainment scale of subjective improvement from the baseline status at 0 and 16 weeks.", 
                "measure": "Goal attainment scale", 
                "safety_issue": "No", 
                "time_frame": "4, 12, 20, 28 weeks"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}